Our mission: To assess the latest basic science, translational, and clinical data so that it may be used to optimize care for patients with rheumatic diseases
More new rheumatologic therapies have been developed in the last fifteen years than in the previous half century. Rheumatologists must regularly sift through a vast assortment of therapeutic options and a wealth of clinical trial data. The Rheumatology Education Group strives to bridge the gap between data and practice with insights that will be equally helpful to both practicing clinicians and our industry partners who are developing these new therapies.
TREG is a group of rheumatologists with over 300 years of collective experience in clinical practice, research, and education.